Key result
Triptolide and methotrexate nanosuspensions reduced myocardial fibrosis and delayed left ventricular remodeling, improving cardiac function in rats with autoimmune myocarditis.
Why the study?
The study was conducted to investigate the effects of triptolide and methotrexate nanosuspensions on left ventricular remodeling, cardiac function, and inflammatory cytokine regulation in autoimmune myocarditis rats.
Do triptolide and methotrexate nanosuspensions improve left ventricular remodeling and cardiac function in rats with autoimmune myocarditis?
Do triptolide and methotrexate nanosuspensions improve left ventricular remodeling and cardiac function in rats with autoimmune myocarditis?
Triptolide and methotrexate nanosuspensions attenuate myocardial fibrosis and left ventricular remodeling in a rat model of autoimmune myocarditis, potentially via inhibition of NF-κB signaling.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in rat autoimmune myocarditis; leaves open translation and safety testing before human trials.
PURPOSE: This study was carried out to investigate the effects of a triptolide (TP) nanosuspension and methotrexate (MTX) nanosuspension on left ventricular remodeling and cardiac function for autoimmune myocarditis (EAM) in rats. The regulating effects on inflammatory cytokines in the peripheral serum and related mechanisms are also discussed. METHODS: First, TP and MTX were prepared as a nanosuspension, and the EAM model was successfully established in rats with cardiac myosin. Then, the effect of TP and MTX suspensions was tested in an EAM model. RESULTS: Results revealed that both TP and MTX suspensions could reduce the degree of myocardial fibrosis and delay the remodeling process of the left ventricle which could further improve cardiac function. Finally, it was found that inflammatory cytokines in the peripheral serum were regulated by the nonspecific immune system and the inhibition of nuclear factor-κB signaling might have partly occurred due to this mechanism. CONCLUSION: In summary, this study provided a complete foundation for EAM therapy of profound clinical relevance.
No takes yet. Share an insight, caveat, or question.
Li et al. (2019) studied Autoimmune myocarditis (EAM). Triptolide (TP) and methotrexate (MTX) nanosuspensions was evaluated on Left ventricular remodeling and cardiac function. Triptolide and methotrexate nanosuspensions reduced myocardial fibrosis and delayed left ventricular remodeling, improving cardiac function in rats with autoimmune myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: